Your browser doesn't support javascript.
loading
Implementing liquid biopsies into clinical decision making for cancer immunotherapy.
Quandt, Dagmar; Dieter Zucht, Hans; Amann, Arno; Wulf-Goldenberg, Anne; Borrebaeck, Carl; Cannarile, Michael; Lambrechts, Diether; Oberacher, Herbert; Garrett, James; Nayak, Tapan; Kazinski, Michael; Massie, Charles; Schwarzenbach, Heidi; Maio, Michele; Prins, Robert; Wendik, Björn; Hockett, Richard; Enderle, Daniel; Noerholm, Mikkel; Hendriks, Hans; Zwierzina, Heinz; Seliger, Barbara.
Affiliation
  • Quandt D; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Dieter Zucht H; Protagen, Dortmund, Germany.
  • Amann A; Department of Haematology and Oncology, Medical University Innsbruck, Innsbruck, Austria.
  • Wulf-Goldenberg A; Experimental Pharmacology and Oncology, Berlin-Buch GmbH, Berlin, Germany.
  • Borrebaeck C; Create Health Translational Cancer Center, Lund University, Lund, Sweden.
  • Cannarile M; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Munich, Germany.
  • Lambrechts D; Laboratory for Translational Genetics, VIB Center for Cancer Biology, Leuven, Belgium.
  • Oberacher H; Institute of Legal Medicine and Core Facility Metabolomics, Medical University of Innsbruck, Innsbruck, Austria.
  • Garrett J; Global Drug Development, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Nayak T; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Kazinski M; Qiagen, Hilden, Germany.
  • Massie C; CRUK Cambridge Institute, Cambridge, UK.
  • Schwarzenbach H; University Medical Center Hamburg-Eppendorf, Department of Tumor Biology Hamburg, Hamburg, Germany.
  • Maio M; Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy.
  • Prins R; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Wendik B; Perkin Elmer, Hamburg, Germany.
  • Hockett R; Biodesix, Boulder, Colorado, USA.
  • Enderle D; Exosome Diagnostics GmbH, Martinsried, Germany.
  • Noerholm M; Exosome Diagnostics GmbH, Martinsried, Germany.
  • Hendriks H; Hendriks Pharmaceutical Consulting, Purmerend, The Netherlands.
  • Zwierzina H; Department of Haematology and Oncology, Medical University Innsbruck, Innsbruck, Austria.
  • Seliger B; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Oncotarget ; 8(29): 48507-48520, 2017 Jul 18.
Article in En | MEDLINE | ID: mdl-28501851
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Germany Country of publication: United States